Home / Resource Library / What does the first line data for polatuzumab vedotin tell us about its role in R/R DLBCL?

What does the first line data for polatuzumab vedotin tell us about its role in R/R DLBCL?

Video interview with Gilles Salles, MD who discusses the use of polatuzumab vedotin for relapsed diffuse large b-cell lymphoma.